ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in March 2023. Updated March 27.
A roundup of FDA’s actions in March 2023.
FDA Output March 2023
×
